Search the Newsreel

AVAH Jumps As Aveanna Healthcare Wins Wave Of Analyst Upgrades

Aveanna Healthcare Holdings Inc. (AVAH) saw its stock rise by 9.11% following strong Q2 2026 results that surpassed analyst estimates for revenue and adjusted EPS, leading to increased guidance for 2026. Major firms like Raymond James, BMO Capital, Deutsche Bank, and UBS raised their …

Annaly Capital Management Inc $NLY Shares Bought by Principal Financial Group Inc.

Principal Financial Group Inc. increased its holdings in Annaly Capital Management Inc. by 3.7% in Q2 2026, purchasing an additional 60,537 shares, bringing its total to 1.68 million shares valued at $37.6 million. Annaly Capital Management (NLY) has received a "Moderate Buy" consensus rating …

Annaly Capital Management Inc $NLY Shares Acquired by TD Asset Management Inc

TD Asset Management Inc. increased its stake in Annaly Capital Management Inc. by 25.1%, bringing its total holdings to 519,768 shares valued at $11.6 million. Annaly Capital Management exceeded analyst expectations with quarterly earnings of $0.79 per share and revenue of $1.82 billion, and …

Pictet Asset Management Holding SA Buys 45,402 Shares of Annaly Capital Management Inc $NLY

Pictet Asset Management Holding SA increased its stake in Annaly Capital Management Inc. by 12.1% during the second quarter, purchasing an additional 45,402 shares and bringing its total holdings to 419,836 shares valued at $9.39 million. Other institutional investors like Vanguard Group Inc., State …

Can Trulieve (TRLV) Turn Rising Losses Into a Sustainable Margin and Cash Flow Strategy?

Aberdeen Group plc Boosts Stock Holdings in Annaly Capital Management Inc $NLY

Bannari Amman Sugars reports standalone net loss of Rs 10.92 crore in the June 2026 quarter

Cannae (NYSE:CNNE) Upgraded at Wall Street Zen

Wall Street Zen has upgraded Cannae (NYSE:CNNE) from a "sell" to a "hold" rating. This upgrade comes as the company exceeded quarterly earnings and revenue estimates. Despite mixed analyst views, Cannae holds a consensus "Hold" rating with an average price target of $16.50, and …

Aveanna Healthcare (NASDAQ:AVAH) Stock Rating Lowered by Wall Street Zen

Aveanna Healthcare (AVAH) Stock Climbs On Higher Guidance And Cash Flow

A Look at Aveanna Healthcare Holdings Inc (AVAH) After 9.2% Gain -- GF Value $5.20 vs Price $12.32

Aveanna Healthcare Holdings Inc (AVAH) recently saw a 9.2% stock gain, pushing its price to $12.32. However, GuruFocus estimates its intrinsic value (GF Value™) at $5.20, indicating significant overvaluation. The stock has an "Above Average" GF Score™ of 63/100, but is flagged for weak …

Avicanna Q2 Results: Gross margin expands to 57% despite revenue dip

What's Going On With Cannara Biotech Inc. Stock Friday?

IM Cannabis reports Q2 results

IM Cannabis press release [https://seekingalpha.com/filing/309949813] (IMCC [https://seekingalpha.com/symbol/IMCC]): Q2 revenue of $7.6 million, compared to $12.7 million in the same period in 2025. * Gross profit of $1.5 million, compared to $3.4 million in the same period in 2025. * Operating loss of $2.1 million, …

AVAH Q2 Earnings Call Highlights Higher Growth Targets

Aveanna Healthcare (NASDAQ:AVAH) Shares Gap Up Following Better-Than-Expected Earnings

Aveanna Healthcare (AVAH) shares gapped up after reporting better-than-expected earnings, with revenue rising 13.7% year over year to $670.5 million and adjusted EPS of $0.22, surpassing analyst estimates. The company also raised its 2026 guidance, projecting revenue above $2.68 billion and adjusted EBITDA above …

Bannari Amman Sugars Posts Quarterly Loss Despite Strong Revenues

Auxly Cannabis Group Inc. (TSX:XLY) Shares Retreat as Valuation Concerns, Cannabis Market Pressure and Investor Caution Weigh on Sentiment

Deutsche Bank Adjusts Aveanna Healthcare PT to $16 From $11.50, Maintains Buy Rating

Deutsche Bank has increased its price target for Aveanna Healthcare Holdings Inc. (AVAH) to $16 from $11.50, while reiterating a Buy rating on the stock. This adjustment reflects an updated outlook from the bank regarding the company's valuation. Earlier the same day, UBS also …

Retirement Systems of Alabama Reduces Holdings in Annaly Capital Management Inc $NLY

Raymond James raises Aveanna Healthcare stock price target on strong results

Raymond James raised its price target on Aveanna Healthcare Holdings (NASDAQ:AVAH) to $15.00 from $13.00, maintaining a Strong Buy rating due to strong Q2 2026 results and an increased EBITDA guidance. The company also reported Q2 2026 revenue of $670.5 million, exceeding analyst forecasts, …

Aveanna stock hits 52-week high after Q2 beat (AVAH:NASDAQ)

Aveanna hits 52-week high after Q2 beat, guidance hike

[Close up image of wooden cubes with alphabet Q2 on office desk.] mohd izzuan Shares of Aveanna Healthcare (AVAH [https://seekingalpha.com/symbol/AVAH]) reached a new 52-week high on Thursday after the home healthcare provider reported better-than-expected Q2 2026 financials and raised its full-year outlook above the …

AleAnna, Inc. Reports Second Quarter 2026 Results

AleAnna, Inc. reported strong financial and operational results for the second quarter of 2026, marking its fifth consecutive quarter of positive Adjusted EBITDA and net income. The company achieved $3.8 million in net income and $4.1 million in Adjusted EBITDA, primarily driven by production …

Tyranna Resources (ASX:TYX): Why Is Its Mining Reset in Focus?

Tyranna Resources (ASX:TYX): What Is Driving Its Mining Story?

Why Is Tyranna Resources (ASX:TYX) Back in Market Focus?

IM Cannabis reports Q2 2026 revenue drop and $4.4M net loss amid operational challenges.

IM Cannabis Corp. reported a significant revenue decrease in Q2 2026, falling to $7.6 million from $12.7 million in Q2 2025, alongside a net loss of $4.4 million. The company is facing ongoing financial challenges, including increased operating losses and a growing shareholders' deficit. …

Insiders In Tyranna Resources Left Out From 33% Price Rise After Disposing Stock

IM Cannabis Q2 Results: EPS Loss Widens to $(0.34), Sales Down 40%

IM Cannabis Posts Deeper Losses and Negative Equity in Second Quarter 2026

IM Cannabis Corp. (IMCC) Stock Falls on Q2 2026 Earnings

IM Cannabis Corp. (IMCC) reported a significant decline in Q2 2026 revenue, down 42.8% year-over-year to $5.4 million, with a net loss of $3.1 million. This financial performance led to a 1.9% drop in the stock price after market close. Institutional investors showed mixed …

IM Cannabis Revenue Falls to C$16.3M as Half-Year Loss Widens